Marinomed Biotech AG (MARI)

Vienna
122.50
0.00(0.00%)
  • Volume:
    149
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    122.00 - 123.50

MARI Overview

Prev. Close
122.5
Day's Range
122-123.5
Revenue
9.33M
Open
122
52 wk Range
89-147
EPS
-4.44
Volume
149
Market Cap
180.65M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
973
P/E Ratio
-
Beta
-
1-Year Change
30.32%
Shares Outstanding
1,474,731
Next Earnings Date
Sep 01, 2021
What is your sentiment on Marinomed Biotech AG?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellBuy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy

Marinomed Biotech AG Company Profile

Marinomed Biotech AG Company Profile

Employees
37
Market
Austria

Marinomed Biotechnologie GmbH is an Austria-based biopharmaceutical company engaged in the pharmaceuticals industry. The Company develops anti-viral and immunological therapies, such as nasal sprays, using the antiviral respiratory technology platform MAVIREX, which target more than 200 different respiratory virus strains based on Carragelose, a red algae derived polymer. The company also offers products for the treatment of influenza, combination products for asthmatics, and others. In addition, the Company develops treatments against type I allergy and autoimmune diseases. The Company operates as a spin-off from the Veterinary University of Vienna.

Read More
  • Bring your anti-viral and anti-corona spray to the world market and go to the moon soon! Give it a try
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.